CompletedNCT00004360

Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus

Studying Arginine vasopressin resistance

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Center for Research Resources (NCRR)
Principal Investigator
Gary L. Robertson
Northwestern University
Intervention
chlorothiazide(drug)
Eligibility
70 years · All sexes
Timeline
1995

Collaborators

Northwestern University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00004360 on ClinicalTrials.gov

Other trials for Arginine vasopressin resistance

Additional recruiting or active studies for the same condition.

See all trials for Arginine vasopressin resistance →

← Back to all trials